Trial intelligence / Profile preview

Levothyroxine therapy and sex hormone levels in women with subclinical hypothyroidism

IRCT20181006041252N6Phase 3Completed

Sponsor
Sabzevar University of Medical Sciences
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Estrogen level and Progesterone level. Started Jan 2019; status: completed.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on IRCT20181006041252N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181006041252N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call